✦ LIBER ✦

Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?

✍ Scribed by J.C.C. Hu; K. Mokbel

Book ID: 117817704
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 40 KB
Volume: 27
Category: Article
ISSN: 0748-7983
DOI: 10.1053/ejso.2000.1078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-erbB2 expression predicts tamoxifen ef

c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

✍ Sabino De Placido; Chiara Carlomagno; Michelino De Laurentiis; AngeloRaffaele Bi 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 639 KB

45 ErbB2 overexpression affects tamoxife

45 ErbB2 overexpression affects tamoxifen efficacy in the adjuvant treatment of node negative operable breast cancer patients

✍ C. Carlomagno; E. Perrone; R. Lauria; M. DeLaurentiis; C. Gallo; A. Morabito; G. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 133 KB

c-erbB-2 (HER-2/neu) protein and drug re

c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy

✍ Laura M. Vargas-Roig; Francisco E. Gago; Olga Tello; María T. Martin de Civetta; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 2 views

Expression of c-erbB-2 protein has been associated with poor prognosis and poor response to chemotherapy in breast cancer patients. In the present prospective study, we have analyzed whether c-erbB-2, p53 and P170 proteins may be determinants of tumor resistance in locally advanced breast cancer pat

Adjuvant CMF +/− tamoxifen (TAM) in prem

Adjuvant CMF +/− tamoxifen (TAM) in premenopausal high-risk patients (PHRPs) with early breast cancer

✍ M. Andersson; C. Kamby; C. Rose; J. Andersen; M.-B. Jensen; H.T. Mouridsen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 133 KB

1405 POSTER DISCUSSION Cyp2C19*2 Polymor

1405 POSTER DISCUSSION Cyp2C19*2 Polymorphism Predicts Benefit of Adjuvant Tamoxifen in ER Positive Postmenopausal Breast Cancer Patients

✍ K. Beelen; R. Koornstra; M. Opdam; T. Severson; A. Vincent; R.J. van Diest; S. L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phosphorylated HER-2 tyrosine kinase and

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

✍ Rosa Giuliani; Virginie Durbecq; Angelo Di Leo; Marianne Paesmans; Denis Larsimo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 636 KB